Cover Image

Antenatal exposure to fenoterol is not associated with the development of retinopathy of prematurity in infants born before 32 weeks of gestation

Despite safety concerns, β2-sympathomimetics are still widely used as tocolytic agents. β-Blockers in turn are used to treat vasculo-proliferative diseases of the newborn such as retinopathy of prematurity (ROP), which may lead to visual impairment and blindness. The scope of this study was to inves...

Full description

Saved in:
Bibliographic Details
Main Authors: Hudalla, Hannes (Author) , Bruckner, Thomas (Author) , Pöschl, Johannes (Author) , Strowitzki, Thomas (Author) , Kuon, Ruben-Jeremias (Author)
Format: Article (Journal)
Language:English
Published: 28 February 2020
In: Archives of gynecology and obstetrics
Year: 2020, Volume: 301, Issue: 3, Pages: 687-692
ISSN:1432-0711
DOI:10.1007/s00404-020-05463-z
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00404-020-05463-z
Get full text
Author Notes:Hannes Hudalla, Thomas Bruckner, Johannes Pöschl, Thomas Strowitzki, Ruben-J. Kuon
Description
Summary:Despite safety concerns, β2-sympathomimetics are still widely used as tocolytic agents. β-Blockers in turn are used to treat vasculo-proliferative diseases of the newborn such as retinopathy of prematurity (ROP), which may lead to visual impairment and blindness. The scope of this study was to investigate whether antenatal exposure to the β2-sympathomimetic fenoterol contributes to the development of ROP.
Item Description:Gesehen am 07.09.2021
Physical Description:Online Resource
ISSN:1432-0711
DOI:10.1007/s00404-020-05463-z

Similar Items